NH Nongwoobio Co., Ltd. (KOSDAQ:054050)
8,160.00
+40.00 (0.49%)
At close: Apr 29, 2026
NH Nongwoobio Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | - | -0 | - | - | - |
| 158,789 | 144,680 | 135,844 | 133,400 | 132,843 | |
Revenue Growth (YoY) | 9.75% | 6.50% | 1.83% | 0.42% | 2.16% |
Cost of Revenue | 81,987 | 73,687 | 70,426 | 68,630 | 70,334 |
Gross Profit | 76,802 | 70,994 | 65,417 | 64,770 | 62,509 |
Selling, General & Admin | 41,291 | 38,605 | 36,096 | 33,730 | 35,409 |
Research & Development | 17,623 | 17,770 | 17,375 | 17,198 | 17,150 |
Amortization of Goodwill & Intangibles | 214 | 279 | 231 | 230 | 340 |
Other Operating Expenses | 817 | 867 | 623 | 584 | 697 |
Operating Expenses | 63,161 | 59,891 | 56,473 | 53,639 | 55,685 |
Operating Income | 13,641 | 11,103 | 8,945 | 11,131 | 6,824 |
Interest Expense | -983 | -1,027 | -1,385 | -1,246 | -973 |
Interest & Investment Income | 1,033 | 862 | 593 | 385 | 212 |
Currency Exchange Gain (Loss) | -578 | 3,591 | 634.66 | 262.86 | 1,740 |
Other Non Operating Income (Expenses) | 130.56 | -716.37 | 991.93 | 1,184 | 859.36 |
EBT Excluding Unusual Items | 13,244 | 13,813 | 9,779 | 11,717 | 8,662 |
Gain (Loss) on Sale of Assets | 2,100 | 236 | 1,016 | 523 | 64 |
Asset Writedown | -278 | -583 | -815 | -1,428 | -1,145 |
Pretax Income | 15,066 | 13,466 | 9,980 | 10,812 | 7,581 |
Income Tax Expense | 2,783 | 2,557 | -188.24 | 925.86 | 628.17 |
Earnings From Continuing Operations | 12,283 | 10,909 | 10,169 | 9,886 | 6,953 |
Earnings From Discontinued Operations | - | - | 152.77 | -64.97 | - |
Net Income to Company | 12,283 | 10,909 | 10,321 | 9,821 | 6,953 |
Minority Interest in Earnings | 5.56 | -69.6 | 11.24 | 57.54 | -22.91 |
Net Income | 12,289 | 10,839 | 10,333 | 9,879 | 6,930 |
Net Income to Common | 12,289 | 10,839 | 10,333 | 9,879 | 6,930 |
Net Income Growth | 13.37% | 4.90% | 4.59% | 42.54% | -26.27% |
Shares Outstanding (Basic) | 16 | 16 | 16 | 16 | 16 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 16 | 16 |
Shares Change (YoY) | -0.08% | 0.03% | - | - | - |
EPS (Basic) | 767.00 | 676.00 | 644.56 | 616.24 | 432.32 |
EPS (Diluted) | 767.00 | 676.00 | 644.56 | 616.24 | 432.00 |
EPS Growth | 13.46% | 4.88% | 4.59% | 42.65% | -26.28% |
Free Cash Flow | 9,946 | 11,402 | 10,197 | 5,066 | 167.19 |
Free Cash Flow Per Share | 620.76 | 711.07 | 636.10 | 316.05 | 10.43 |
Dividend Per Share | - | - | 200.000 | 200.000 | 200.000 |
Gross Margin | 48.37% | 49.07% | 48.16% | 48.55% | 47.05% |
Operating Margin | 8.59% | 7.67% | 6.59% | 8.34% | 5.14% |
Profit Margin | 7.74% | 7.49% | 7.61% | 7.41% | 5.22% |
Free Cash Flow Margin | 6.26% | 7.88% | 7.51% | 3.80% | 0.13% |
EBITDA | 20,161 | 17,308 | 14,318 | 17,101 | 13,732 |
EBITDA Margin | 12.70% | 11.96% | 10.54% | 12.82% | 10.34% |
D&A For EBITDA | 6,519 | 6,205 | 5,374 | 5,970 | 6,908 |
EBIT | 13,641 | 11,103 | 8,945 | 11,131 | 6,824 |
EBIT Margin | 8.59% | 7.67% | 6.59% | 8.34% | 5.14% |
Effective Tax Rate | 18.47% | 18.99% | - | 8.56% | 8.29% |
Advertising Expenses | 930 | 992 | 970 | 937 | 1,442 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.